Drug royalty ruling leaves scars on biotech and its sibling company

The dispute centered on how to use royalties from the GlaxoSmithKline blockbuster COPD and asthma drug Trelegy.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news